There are 2934 resources available
1523 - Natural dendritic cell vaccinations generate immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Presenter: Jeroen Creemers
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
1460 - Active immunization with immune checkpoint inhibitors-mimotope elicits strong anti-tumor effect against Her-2/neu-expressing tumors
Presenter: Joshua Tobias
Session: Poster Discussion 1 – Immunotherapy of cancer
Resources:
Abstract
4638 - Health-Related Quality of Life (HRQoL) Impact of Pembrolizumab (P) Versus Chemotherapy (C) as First-Line (1L) Treatment in PD-L1–Positive Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Presenter: Eric Van Cutsem
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
5708 - Chemotherapy for Frail and Elderly Patients (pts) with Advanced Gastroesophageal Cancer (aGOAC): Quality of Life (QoL) results from the GO2 Phase III Trial
Presenter: Peter Hall
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 673PD and 674PD
Presenter: Hanneke van Laarhoven
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA45, LBA46, 675PD and 676PD
Presenter: Florian Lordick
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 677PD, 678PD, 679PD and 680PD
Presenter: Russell Petty
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Poster Discussion – Gastrointestinal tumours, non-colorectal - Invited Discussant 681PD and LBA47
Presenter: Ana Raimundo
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
3222 - Nab-paclitaxel (Nab) plus Gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): the GAP trial, a GISCAD phase II comparative randomized trial.
Presenter: Stefano Cascinu
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
5184 - Perioperative FLOT + anti-PD-L1 avelumab (FLOT-A) chemo-immunotherapy in resectable oesophagogastric adenocarcinoma (OGA): safety and biomarker data from the ICONIC trial safety run-in
Presenter: Michael Davidson
Session: Poster Discussion – Gastrointestinal tumours, non-colorectal
Resources:
Abstract